Skip to main content
Erschienen in: World Journal of Urology 11/2015

01.11.2015 | Original Article

Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis

verfasst von: Rebecca L. O’Malley, Matthew H. Hayn, Katherine A. Brewer, Willie Underwood III, Nicholas J. Hellenthal, Hyung L. Kim, Igor Sorokin, Thomas Schwaab

Erschienen in: World Journal of Urology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is unclear. To assess whether PN provides adequate cancer control in high-risk disease (HRD), survival outcomes were compared in both a population-based cohort and an institutional cohort.

Methods

Surveillance, Epidemiology, and End Results database and a prospectively maintained institutional database were queried for patients with RCC who underwent PN or RN for a localized tumor ≤7 cm and were found to have high-grade and/or high-stage disease (HRD). Cancer-specific (CSS) or recurrence-free survival (RFS) and overall survival (OS) were primary outcomes measured and were compared between those who underwent PN and RN using multivariable Cox proportional hazards and propensity analysis.

Results

The population cohort consisted of 12,757 (24.9 %) patients with HRD, 85.2 and 14.8 % of which underwent RN and PN, respectively. RN was not associated with CSS (HR 1.23, p = 0.08) but was independently associated with poor OS (HR 1.16, p = 0.031). Propensity analysis showed that RN resulted in a 20 % increased risk of death from all causes (p = 0.008). In the institutional cohort, of 317 patients, 35.9 % had HRD, 56 and 52 of which underwent RN and PN, respectively. Adjusting for age-adjusted Charlson index, RN was a predictor of poor OS (OR 6.20, p = 0.041). Propensity analysis showed that RFS and OS were not related to nephrectomy type (RN HR 0.65, p = 0.627 and RN HR 1.70, p = 0.484).

Conclusions

In patients with pathologic high-risk RCC, partial excision is associated with similar cancer control as compared to radical excision.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA 60:277–300PubMed Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA 60:277–300PubMed
2.
Zurück zum Zitat Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740PubMedCentralCrossRefPubMed Huang WC, Levey AS, Serio AM et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279CrossRefPubMed
4.
Zurück zum Zitat Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552CrossRefPubMed Van Poppel H, Da Pozzo L, Albrecht W et al (2011) A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 59:543–552CrossRefPubMed
5.
Zurück zum Zitat Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol 163:730–736CrossRefPubMed
6.
Zurück zum Zitat Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2004) Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171:1066–1070CrossRefPubMed Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2004) Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 171:1066–1070CrossRefPubMed
7.
Zurück zum Zitat Patard JJ, Shvarts O, Lam JS et al (2004) Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171:2181–2185CrossRefPubMed Patard JJ, Shvarts O, Lam JS et al (2004) Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 171:2181–2185CrossRefPubMed
8.
Zurück zum Zitat Thompson RH, Boorjian SA, Lohse CM et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471CrossRefPubMed Thompson RH, Boorjian SA, Lohse CM et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179:468–471CrossRefPubMed
9.
Zurück zum Zitat Weight CJ, Larson BT, Gao T et al (2010) Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 76:631–637CrossRefPubMed Weight CJ, Larson BT, Gao T et al (2010) Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 76:631–637CrossRefPubMed
10.
Zurück zum Zitat Kontak JA, Campbell SC (2003) Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467–480CrossRefPubMed Kontak JA, Campbell SC (2003) Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467–480CrossRefPubMed
11.
Zurück zum Zitat Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853CrossRefPubMed
13.
Zurück zum Zitat Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174CrossRefPubMed Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174CrossRefPubMed
14.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralCrossRefPubMed Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 5(150):604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 5(150):604–612CrossRef
16.
Zurück zum Zitat Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 15(139):137–147CrossRef Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 15(139):137–147CrossRef
17.
Zurück zum Zitat D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 15(17):2265–2281CrossRef D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 15(17):2265–2281CrossRef
18.
Zurück zum Zitat Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51:1606–1615CrossRefPubMed Van Poppel H, Da Pozzo L, Albrecht W et al (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51:1606–1615CrossRefPubMed
19.
Zurück zum Zitat Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323CrossRefPubMed
20.
Zurück zum Zitat Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC, Fergany AF (2011) Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology 77:1142–1146CrossRefPubMed Weight CJ, Lythgoe C, Unnikrishnan R, Lane BR, Campbell SC, Fergany AF (2011) Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology 77:1142–1146CrossRefPubMed
21.
Zurück zum Zitat Dulabon LM, Lowrance WT, Russo P, Huang WC (2010) Trends in renal tumor surgery delivery within the United States. Cancer 2010(116):2316–2321 Dulabon LM, Lowrance WT, Russo P, Huang WC (2010) Trends in renal tumor surgery delivery within the United States. Cancer 2010(116):2316–2321
22.
Zurück zum Zitat Breda A, Anterasian C, Belldegrun A (2010) Management and outcomes of tumor recurrence after focal ablation renal therapy. J Endourol/Endourol Soc 24:749–752CrossRef Breda A, Anterasian C, Belldegrun A (2010) Management and outcomes of tumor recurrence after focal ablation renal therapy. J Endourol/Endourol Soc 24:749–752CrossRef
23.
Zurück zum Zitat Tomaszewski JJ, Uzzo RG, Kutikov A et al (2014) Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status. Urology 83:843–850PubMedCentralCrossRefPubMed Tomaszewski JJ, Uzzo RG, Kutikov A et al (2014) Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status. Urology 83:843–850PubMedCentralCrossRefPubMed
Metadaten
Titel
Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis
verfasst von
Rebecca L. O’Malley
Matthew H. Hayn
Katherine A. Brewer
Willie Underwood III
Nicholas J. Hellenthal
Hyung L. Kim
Igor Sorokin
Thomas Schwaab
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 11/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1538-z

Weitere Artikel der Ausgabe 11/2015

World Journal of Urology 11/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.